Type A Allatostatin I is a tridecapeptide. Allatostatins are pleiotropic neuropeptides for inhibition of juvenile hormone synthesis in insects.
Type A Allatostatin I is a neuropeptide originally identified in insects, where it functions as a potent inhibitor of juvenile hormone synthesis and plays a critical role in the regulation of feeding and other physiological processes. Structurally, it belongs to the allatostatin peptide family, characterized by a conserved C-terminal motif that mediates binding to specific G protein-coupled receptors (GPCRs). Its unique sequence and bioactivity have made it a valuable tool in neurobiology, endocrinology, and peptide signaling research. The peptide's capacity to modulate neural circuits and hormonal pathways in invertebrates has also inspired cross-disciplinary interest in its mechanisms of action, receptor specificity, and potential analog development for experimental applications.
Neuroscience research: Type A Allatostatin I serves as a key probe for dissecting inhibitory signaling pathways in insect nervous systems. By selectively activating allatostatin receptors, it enables precise investigation of how neuropeptides regulate neuronal excitability, synaptic transmission, and network dynamics. Researchers employ this peptide to map neural circuits involved in behaviors such as feeding, locomotion, and circadian rhythm regulation, providing insights into the conserved principles of neuromodulation across species.
Endocrine system studies: The peptide is widely utilized to study the control of juvenile hormone biosynthesis in insects, a process fundamental to development, metamorphosis, and reproduction. By applying it to in vitro or in vivo models, scientists can manipulate juvenile hormone levels and elucidate the downstream effects on gene expression, tissue differentiation, and physiological timing. Such experiments help clarify the molecular mechanisms by which peptide hormones orchestrate complex life cycle transitions in arthropods.
Peptide receptor characterization: Type A Allatostatin I is instrumental in the functional analysis of GPCRs that recognize allatostatins. Using ligand-binding assays, receptor activation studies, and signaling pathway analyses, researchers can determine receptor specificity, affinity, and downstream signaling cascades. These investigations are crucial for understanding the evolution and diversity of peptide-receptor interactions and for identifying potential pharmacological targets in pest management or synthetic biology.
Peptide analog development: The defined structure and receptor selectivity of this neuropeptide make it a template for the design of synthetic analogs with altered stability, potency, or receptor preference. Chemists and biologists use it to develop and test modified peptides that may serve as experimental tools for dissecting signaling pathways or as prototypes for environmentally friendly insect control agents. Structure-activity relationship (SAR) studies based on this molecule have expanded knowledge of peptide modification strategies and bioactivity optimization.
Comparative physiology: Beyond its primary role in insects, Type A Allatostatin I is valuable in comparative studies exploring the conservation and divergence of neuropeptide signaling across taxa. By applying the peptide to diverse invertebrate models, researchers can assess the functional relevance of allatostatin pathways in different physiological contexts and evolutionary lineages. Such research contributes to a broader understanding of how peptide hormones shape organismal adaptation and interspecies variation in regulatory networks.
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More